A New Drug For A Relentless Brain Disease

A New Drug For A Relentless Brain Disease

Suivant

Why you can't stop scrolling: the science of 'dark flow'

You pick up your phone to do one quick task, and suddenly 20 minutes have flown by without you even noticing. How do apps do that to you? Science journalist Michaeleen Doucleff felt like her phone had superglue on it, holding her on it for hours each day while draining her of tim ...  Afficher plus

This distant planet has wild weather and gemstone clouds

For many astronomers and astrophysicists there are two distinct, important periods: before the James Webb Space Telescope – and after. It has powered many scientific discoveries since it came online, including two at the heart of this episode: insights into one of Neptune’s moons ...  Afficher plus

Épisodes Recommandés

Declining ALS Patients Are Waiting On The FDA's Next Move
Big Take

For many years, pharmaceutical companies have tried and failed to find a treatment to slow symptoms of ALS–the debilitating, fatal illness also known as Lou Gehrig’s Disease. A potentially promising new drug from Biogen may offer some relief to those afflicted with an uncommon an ...  Afficher plus

Prognosis, a New Show From Bloomberg
Prognosis: Misconception

Where does a medical cure come from? 100 years ago, it wasn't uncommon for scientists to test medicines by taking a dose themselves. As medical technologies get cheaper and more accessible, patients and DIY tinkerers are trying something similar—and mainstream medicine is racing ...  Afficher plus

101: Have we found a cure for Alzheimer's, Parkinson's, Depression and ALS? | Dr. Jay Lombard
The Neuro Experience

If you’ve ever “gone with your gut” to make a decision or felt “butterflies in your stomach” when nervous, you’re likely getting signals from an unexpected source: your second brain. Hidden in the walls of the digestive system, this “brain in your gut” is revolutionizing medicine ...  Afficher plus

The Promise of a New Treatment
Prognosis: Misconception

The drug company Eli Lilly is about to start testing its Covid-19 antibody drug in nursing homes. Vaccines may not work as well on elderly people or those with compromised immune systems. Since these are the very groups most at risk for severe disease or death if they contract th ...  Afficher plus